Bionano Genomics Statistics
Total Valuation
BMV:BNGO has a market cap or net worth of MXN 255.85 million. The enterprise value is 604.45 million.
Market Cap | 255.85M |
Enterprise Value | 604.45M |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +123.37% |
Shares Change (QoQ) | +15.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.40 |
PB Ratio | 0.35 |
P/TBV Ratio | 0.48 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.26 |
EV / Sales | 1.00 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.42 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.77.
Current Ratio | 1.06 |
Quick Ratio | 0.38 |
Debt / Equity | 0.77 |
Debt / EBITDA | n/a |
Debt / FCF | -0.40 |
Interest Coverage | -37.46 |
Financial Efficiency
Return on equity (ROE) is -170.33% and return on invested capital (ROIC) is -40.02%.
Return on Equity (ROE) | -170.33% |
Return on Assets (ROA) | -32.76% |
Return on Invested Capital (ROIC) | -40.02% |
Return on Capital Employed (ROCE) | -193.96% |
Revenue Per Employee | 6.48M |
Profits Per Employee | -23.58M |
Employee Count | 100 |
Asset Turnover | 0.21 |
Inventory Turnover | 1.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.74% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -88.74% |
50-Day Moving Average | 83.76 |
200-Day Moving Average | 339.83 |
Relative Strength Index (RSI) | 60.05 |
Average Volume (20 Days) | 22 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.48 |
Income Statement
In the last 12 months, BMV:BNGO had revenue of MXN 641.29 million and -2.33 billion in losses. Loss per share was -1,836.46.
Revenue | 641.29M |
Gross Profit | 7.92M |
Operating Income | -1.59B |
Pretax Income | -2.33B |
Net Income | -2.33B |
EBITDA | -1.30B |
EBIT | -1.59B |
Loss Per Share | -1,836.46 |
Balance Sheet
The company has 197.43 million in cash and 568.80 million in debt, giving a net cash position of -371.36 million.
Cash & Cash Equivalents | 197.43M |
Total Debt | 568.80M |
Net Cash | -371.36M |
Net Cash Per Share | n/a |
Equity (Book Value) | 737.12M |
Book Value Per Share | 395.16 |
Working Capital | 44.70M |
Cash Flow
In the last 12 months, operating cash flow was -1.44 billion and capital expenditures -2.15 million, giving a free cash flow of -1.44 billion.
Operating Cash Flow | -1.44B |
Capital Expenditures | -2.15M |
Free Cash Flow | -1.44B |
FCF Per Share | n/a |
Margins
Gross Margin | 1.23% |
Operating Margin | -247.85% |
Pretax Margin | -363.87% |
Profit Margin | n/a |
EBITDA Margin | -202.29% |
EBIT Margin | -247.85% |
FCF Margin | n/a |
Dividends & Yields
BMV:BNGO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -123.37% |
Shareholder Yield | -123.37% |
Earnings Yield | -912.31% |
FCF Yield | -562.16% |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.0166666667.
Last Split Date | Jan 27, 2025 |
Split Type | Reverse |
Split Ratio | 0.0166666667 |
Scores
BMV:BNGO has an Altman Z-Score of -14.84. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -14.84 |
Piotroski F-Score | n/a |